Momose Y, Mabuchi Y, Shigematsu A
Institute of Whole Body Metabolism Shiroi, Chiba, Japan.
Eur J Drug Metab Pharmacokinet. 1988 Oct-Dec;13(4):285-94. doi: 10.1007/BF03190092.
Secondary proliferous melanoic tumors grew at 100% of probability in a liver lobe of C57BL/6 mouse with a piece of B16 melanoma tumor embedded successfully in the lobe. Clear border between host liver tissues and the embedded tumor piece was observed 14 days after embedding. No division image was noted in cells of the embedded tumor piece. In all regions surrounding the embedded tumor piece, there were few accumulations of leucocytes, lymphocytes, or giant cells, indicating a strong likelihood of immune reaction or antigen-antibody reaction, although there was active formation of fibroblast bunds and production of lysosomal enzymes. Secondary proliferous melanoic tumors developed in the environment of liver tissue separately from the embedded tumor location. Results of 14C-thymidine-nuclear labeling of embedded tumor cells showed that the majority of the labeled cells did not migrate or divide. In the case of 14C-thymidine-labeling of host liver tissue cells, results indicated no transfer of 14C-radioactivity into nuclei of embedded tumor cells, although there was positive distribution of 14C-radioactivity into nuclei of proliferous cells in the secondary tumor, a newly developed melanoic cell group. When prelabeling was performed the average density of autoradiographic image over the secondary tumor was equivalent to that over the normal liver tissue at the early stage such as 7 days after embedding and decreased with time after that. The newly developed melanoic cells were particularly exciting and proliferous, because they received much more labeling of 14C-thymidine as compared to liver tissue cells that was provided by one shot labeling of the radioactive tracer 1 h. before sacrifice of tumor embedded mice. There was no development of secondary melanoic cells in the liver lobe in case of embedding of a tumor piece previously by wrapping with a membranefilter, less 5 microns in pore size.
在成功将一块B16黑色素瘤肿瘤嵌入叶内的C57BL/6小鼠的肝叶中,继发性增殖性黑色素瘤肿瘤以100%的概率生长。嵌入后14天观察到宿主肝组织与嵌入的肿瘤块之间有清晰的边界。嵌入的肿瘤块细胞中未观察到分裂图像。在嵌入的肿瘤块周围的所有区域,白细胞、淋巴细胞或巨细胞的聚集很少,这表明尽管有成纤维细胞束的活跃形成和溶酶体酶的产生,但免疫反应或抗原 - 抗体反应的可能性很大。继发性增殖性黑色素瘤肿瘤在与嵌入肿瘤位置分开的肝组织环境中发展。嵌入肿瘤细胞的14C - 胸腺嘧啶核苷核标记结果表明,大多数标记细胞不迁移或分裂。在宿主肝组织细胞的14C - 胸腺嘧啶核苷标记的情况下,结果表明14C - 放射性没有转移到嵌入肿瘤细胞的细胞核中,尽管在继发性肿瘤(一个新形成的黑色素细胞群)的增殖细胞核中有14C - 放射性的阳性分布。当进行预标记时,在嵌入后7天等早期阶段,继发性肿瘤上的放射自显影图像的平均密度与正常肝组织上的相当,之后随时间降低。新形成的黑色素细胞特别活跃且增殖,因为与在处死肿瘤嵌入小鼠前1小时一次性注射放射性示踪剂的肝组织细胞相比,它们接受了更多的14C - 胸腺嘧啶核苷标记。如果事先用孔径小于5微米的膜过滤器包裹肿瘤块进行嵌入,则肝叶中不会形成继发性黑色素细胞。